BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 35918217)

  • 1. The role of genetic risk factors of Alzheimer's disease in synaptic dysfunction.
    Fu WY; Ip NY
    Semin Cell Dev Biol; 2023 Apr; 139():3-12. PubMed ID: 35918217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of synaptic microRNAs in Alzheimer's disease.
    Kumar S; Reddy PH
    Biochim Biophys Acta Mol Basis Dis; 2020 Dec; 1866(12):165937. PubMed ID: 32827646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of pathological tau in synaptic dysfunction in Alzheimer's diseases.
    Wu M; Zhang M; Yin X; Chen K; Hu Z; Zhou Q; Cao X; Chen Z; Liu D
    Transl Neurodegener; 2021 Nov; 10(1):45. PubMed ID: 34753506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial Aspects of Synaptic Dysfunction in Alzheimer's Disease.
    Cai Q; Tammineni P
    J Alzheimers Dis; 2017; 57(4):1087-1103. PubMed ID: 27767992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative Stress, Synaptic Dysfunction, and Alzheimer's Disease.
    Tönnies E; Trushina E
    J Alzheimers Dis; 2017; 57(4):1105-1121. PubMed ID: 28059794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synaptic Plasticity, Dementia and Alzheimer Disease.
    Skaper SD; Facci L; Zusso M; Giusti P
    CNS Neurol Disord Drug Targets; 2017; 16(3):220-233. PubMed ID: 28088900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging pathways driving early synaptic pathology in Alzheimer's disease.
    Briggs CA; Chakroborty S; Stutzmann GE
    Biochem Biophys Res Commun; 2017 Feb; 483(4):988-997. PubMed ID: 27659710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synaptic genes are extensively downregulated across multiple brain regions in normal human aging and Alzheimer's disease.
    Berchtold NC; Coleman PD; Cribbs DH; Rogers J; Gillen DL; Cotman CW
    Neurobiol Aging; 2013 Jun; 34(6):1653-61. PubMed ID: 23273601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamics of the Complement, Cytokine, and Chemokine Systems in the Regulation of Synaptic Function and Dysfunction Relevant to Alzheimer's Disease.
    Jiang S; Bhaskar K
    J Alzheimers Dis; 2017; 57(4):1123-1135. PubMed ID: 28372329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synaptic mitochondrial pathology in Alzheimer's disease.
    Du H; Guo L; Yan SS
    Antioxid Redox Signal; 2012 Jun; 16(12):1467-75. PubMed ID: 21942330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synapses in neurodegenerative diseases.
    Bae JR; Kim SH
    BMB Rep; 2017 May; 50(5):237-246. PubMed ID: 28270301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aβ mediates F-actin disassembly in dendritic spines leading to cognitive deficits in Alzheimer's disease.
    Kommaddi RP; Das D; Karunakaran S; Nanguneri S; Bapat D; Ray A; Shaw E; Bennett DA; Nair D; Ravindranath V
    J Neurosci; 2018 Jan; 38(5):1085-1099. PubMed ID: 29246925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The transcriptional landscape of Alzheimer's disease and its association with Wnt signaling pathway.
    Martínez M; Inestrosa NC
    Neurosci Biobehav Rev; 2021 Sep; 128():454-466. PubMed ID: 34224789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epileptic Mechanisms Shared by Alzheimer's Disease: Viewed via the Unique Lens of Genetic Epilepsy.
    Kang JQ
    Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of Oxidative Stress and Synapse Dysfunction in the Pathogenesis of Alzheimer's Disease: Understanding the Therapeutics Strategies.
    Kamat PK; Kalani A; Rai S; Swarnkar S; Tota S; Nath C; Tyagi N
    Mol Neurobiol; 2016 Jan; 53(1):648-661. PubMed ID: 25511446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diverse and Composite Roles of miRNA in Non-Neuronal Cells and Neuronal Synapses in Alzheimer's Disease.
    Li X; Chen SC; Ip JPK
    Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central role for NMDA receptors in redox mediated impairment of synaptic function during aging and Alzheimer's disease.
    Foster TC; Kyritsopoulos C; Kumar A
    Behav Brain Res; 2017 Mar; 322(Pt B):223-232. PubMed ID: 27180169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synaptic Dysfunction in Alzheimer's Disease: Aβ, Tau, and Epigenetic Alterations.
    Li K; Wei Q; Liu FF; Hu F; Xie AJ; Zhu LQ; Liu D
    Mol Neurobiol; 2018 Apr; 55(4):3021-3032. PubMed ID: 28456942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stress-Induced Synaptic Dysfunction and Neurotransmitter Release in Alzheimer's Disease: Can Neurotransmitters and Neuromodulators be Potential Therapeutic Targets?
    Jha SK; Jha NK; Kumar D; Sharma R; Shrivastava A; Ambasta RK; Kumar P
    J Alzheimers Dis; 2017; 57(4):1017-1039. PubMed ID: 27662312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early calcium dysregulation in Alzheimer's disease: setting the stage for synaptic dysfunction.
    Chakroborty S; Stutzmann GE
    Sci China Life Sci; 2011 Aug; 54(8):752-62. PubMed ID: 21786198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.